Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Christensen

Showing results (431-440 of 510) with videos related to

Pageof 51
Sort By:
Journal of the American Chemical Society|June 6, 2003
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimersJohn H Griffin, Martin S Linsell, Matthew B Nodwell, et al.
Molecular Cancer Therapeutics|March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor TherapyDavid M Briere, Shuai Li, Andrew Calinisan, et al.
Science Translational Medicine|November 11, 2011
Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastomaScott C Bresler, Andrew C Wood, Elizabeth A Haglund, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 19, 2014
Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjectsTheodore R Johnson, Weiwei Tan, Lance Goulet, et al.
Science (New York, N.Y.)|September 22, 2018
Measurement of a superconducting qubit with a microwave photon counterA Opremcak, I V Pechenezhskiy, C Howington, et al.
Nucleic Acids Research|February 14, 2014
An improved predictive recognition model for Cys(2)-His(2) zinc finger proteinsAnkit Gupta, Ryan G Christensen, Heather A Bell, et al.
Bioorganic & Medicinal Chemistry|August 4, 2022
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitorsChristopher R Smith, Ruth Aranda, James G Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer modelsCathy C Zhang, Adam Pavlicek, Qin Zhang, et al.
Molecular Cancer Therapeutics|March 6, 2012
Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitorHelen Y Zou, Qiuhua Li, Joseph H Lee, et al.
Cancer Research|May 3, 2008
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitorsUltan McDermott, A John Iafrate, Nathanael S Gray, et al.
Pageof 51

Showing results (431-440 of 510) with videos related to

Sort By:
Pageof 51
Journal of the American Chemical Society|June 6, 2003
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimersJohn H Griffin, Martin S Linsell, Matthew B Nodwell, et al.
Molecular Cancer Therapeutics|March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor TherapyDavid M Briere, Shuai Li, Andrew Calinisan, et al.
Science Translational Medicine|November 11, 2011
Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastomaScott C Bresler, Andrew C Wood, Elizabeth A Haglund, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 19, 2014
Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjectsTheodore R Johnson, Weiwei Tan, Lance Goulet, et al.
Science (New York, N.Y.)|September 22, 2018
Measurement of a superconducting qubit with a microwave photon counterA Opremcak, I V Pechenezhskiy, C Howington, et al.
Nucleic Acids Research|February 14, 2014
An improved predictive recognition model for Cys(2)-His(2) zinc finger proteinsAnkit Gupta, Ryan G Christensen, Heather A Bell, et al.
Bioorganic & Medicinal Chemistry|August 4, 2022
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitorsChristopher R Smith, Ruth Aranda, James G Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer modelsCathy C Zhang, Adam Pavlicek, Qin Zhang, et al.
Molecular Cancer Therapeutics|March 6, 2012
Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitorHelen Y Zou, Qiuhua Li, Joseph H Lee, et al.
Cancer Research|May 3, 2008
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitorsUltan McDermott, A John Iafrate, Nathanael S Gray, et al.
Pageof 51